Premier Path Wealth Partners
RMD icon

Premier Path Wealth Partners’s ResMed RMD Stock Holding History

Premier Path Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$413K Buy
1,869
+307
+20% +$67K 0.05% 290
2026
Q2 		$304K Sell
1,562
-151
-9% -$31.3K 0.04% 358
2026
Q1 		$384K Buy
1,713
+334
+24% +$83.2K 0.05% 312
2025
Q4 		$332K Sell
1,379
-97
-7% -$24.8K 0.04% 312
2025
Q3 		$404K Buy
1,476
+171
+13% +$46.7K 0.05% 289
2025
Q2 		$337K Buy
1,305
+161
+14% +$38.4K 0.05% 308
2025
Q1 		$256K Buy
1,144
+8
+0.7% +$1.87K 0.04% 328
2024
Q4 		$260K Buy
1,136
+28
+3% +$6.74K 0.04% 324
2024
Q3 		$270K Buy
1,108
+32
+3% +$7.15K 0.04% 318
2024
Q2 		$206K Buy
+1,076
New +$218K 0.04% 353

Other funds holding RMD

Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
Washington Trust Advisors
Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Addenda Capital
Addenda Capital Montreal, Quebec, Canada $3.78B AUM 23.53% 1-Year Est. Return

Premier Path Wealth Partners's RMD Position: Q3 2026 in Review

Premier Path Wealth Partners increased its ResMed (RMD) stake by 20% in Q3 2026, buying an estimated $67K and bringing the position to 1,869 shares worth $413K. The position accounts for 0.05% of the portfolio, ranked #290.

Premier Path Wealth Partners first reported a position in RMD in Q2 2024 and has held it in 10 quarters since. 174 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Premier Path Wealth Partners held 1,869 shares of ResMed worth $413K as of Q3 2026.
  • Premier Path Wealth Partners bought 307 ResMed shares in Q3 2026, an estimated $67K.
  • ResMed made up 0.05% of Premier Path Wealth Partners's portfolio in Q3 2026, its #290 holding.
  • Premier Path Wealth Partners first reported a position in ResMed in Q2 2024 and has held it in 10 quarters since.
  • 174 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Premier Path Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.